TScan Therapeutics
TCRX
TCRX
28 hedge funds and large institutions have $69.9M invested in TScan Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 28 → 28 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Holders
28
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$13.1M | |
| 2 | +$12.5M | |
| 3 | +$8.63M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$7.47M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.66M |
Top Sellers
| 1 | -$629K | |
| 2 | -$497K | |
| 3 | -$163K | |
| 4 |
Morgan Stanley
New York
|
-$57.1K |
| 5 |
CC
Cannell Capital
Alta,
Wyoming
|
-$30.8K |